Calcitonin Increases the Activity of ERK and Bcl-2 in Osteoclasts and Reduces SDCP-induced Osteoclasts Apoptosis
碩士 === 國立陽明大學 === 解剖學及細胞生物學研究所 === 98 === Aim : To study what the mechanism of calcitonin reduced osteoclasts apoptosis. SDCP is the newly anti-resorption drug in recent years but it mechanism of anti-resorption is not clear. To study the mechanism of calcitonin reduced SDCP-induced osteoclasts apop...
Main Authors: | Yi-Chein Huang, 黃義謙 |
---|---|
Other Authors: | Tien-Hua Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/98546731906582604054 |
Similar Items
-
Calcitonin reduces SDCP-induced osteoclast apoptosis and increases its efficacy to treat osteopenic rat
by: Chen, Weiyu, et al.
Published: (2011) -
Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.
by: Yi-Jie Kuo, et al.
Published: (2012-01-01) -
Study of calcitonin-induced survival pathways in osteoclasts
by: Chia-Yin Li, et al.
Published: (2008) -
The Role of Protein Tyrosine Phosphatases in Calcitonin Effects in Osteoclasts
by: Hsiao-Tung Liu, et al.
Published: (2006) -
ERK5 activation is essential for osteoclast differentiation.
by: Shigeru Amano, et al.
Published: (2015-01-01)